Progress in liver transplantation during the past 30 years has been dramatic. The complexities of the operation have been standardized, candidate mortality has been objectified (Model for End-stage Liver Disease [MELD]), and survival has been maximized. Historically, the use of “marginal” liver allografts has often resulted in suboptimal results; thus, these grafts were often discarded except in the direst of circumstances. The more contemporary era of liver transplantation, perhaps the MELD era, has seen increasing use of marginal allografts owing to many factors, including the proliferation of transplant centers, growing transplant wait lists, intense competition for organs, and improvements in surgical, anesthetic, and critical care skills.1 The evaluation of the marginal donor allograft by Zhang et al2 in this issue of JAMA Surgery makes the case that earlier definitions of marginal are no longer accurate.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Schenk AD, Washburn WK. A Move to Demarginalize the Liver Donor Allograft. JAMA Surg. 2020;155(10):932–933. doi:10.1001/jamasurg.2020.2520
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: